UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 129

Sortiert nach

Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2018-01, Vol.77 (1), p.48

2018

Volltextzugriff (PDF)

Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study

Annals of the rheumatic diseases, 2017-10, Vol.76 (10), p.1693

2017

Volltextzugriff (PDF)

The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients

Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.998-1003

2015

Volltextzugriff (PDF)

Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis

PloS one, 2017-03, Vol.12 (3), p.e0174656-e0174656

2017

Volltextzugriff (PDF)

How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis

BMC musculoskeletal disorders, 2014-11, Vol.15 (1), p.368-368, Article 368

2014

Volltextzugriff (PDF)

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

Annals of the rheumatic diseases, 2011-09, Vol.70 (9), p.1575-1580

2011

Volltextzugriff (PDF)

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Arthritis research & therapy, 2016-02, Vol.18 (50), p.50-50, Article 50

2016

Volltextzugriff (PDF)

Rituximab treatment in patients with refractory inflammatory myopathies

Rheumatology (Oxford, England), 2011-12, Vol.50 (12), p.2206-2213

2011

Volltextzugriff (PDF)

Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs

Journal of rheumatology, 2009-10, Vol.36 (10), p.2164

2009

Volltextzugriff (PDF)

A tailored-guided internet-based cognitive-behavioral intervention for patients with rheumatoid arthritis as an adjunct to standard rheumatological care: results of a randomized controlled trial

Pain (Amsterdam), 2017-05, Vol.158 (5), p.868-878

2017

Volltextzugriff (PDF)

Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries

Rheumatology (Oxford, England), 2017-07, Vol.56 (7), p.1102-1110

2017

Volltextzugriff (PDF)

Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort

Arthritis research & therapy, 2012-11, Vol.14 (6), p.R254-R254

2012

Volltextzugriff (PDF)

Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry

BMC musculoskeletal disorders, 2013-12, Vol.14 (1), p.350-350, Article 350

2013

Volltextzugriff (PDF)

Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry

Annals of the rheumatic diseases, 2013-06, Vol.72 (6), p.895-900

2013

Volltextzugriff (PDF)

A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry

Annals of the rheumatic diseases, 2012-06, Vol.71 (6), p.845-850

2012

Volltextzugriff (PDF)

Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology

Arthritis research & therapy, 2014-05, Vol.16 (3), p.R111-R111

2014

Volltextzugriff (PDF)

Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration

Annals of the rheumatic diseases, 2012-03, Vol.71 (3), p.374-377

2012

Volltextzugriff (PDF)

Adalimumab drug and antidrug antibody levels do not predict flare risk after stopping adalimumab in RA patients with low disease activity

Rheumatology (Oxford, England), 2019-03, Vol.58 (3), p.427-431

2019

Volltextzugriff (PDF)

Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis

Annals of the rheumatic diseases, 2007-11, Vol.66 (11), p.1503-1507

2007

Volltextzugriff (PDF)

Time to achieve remission determines time to be in remission

Arthritis research & therapy, 2010-01, Vol.12 (3), p.R97-R97

2010

Volltextzugriff (PDF)

Implementation of the EULAR cardiovascular risk management guideline in patients with rheumatoid arthritis: results of a successful collaboration between primary and secondary care

Annals of the rheumatic diseases, 2018-04, Vol.77 (4), p.480

2018

Volltextzugriff (PDF)

The provisional ACR/EULAR definition of remission in RA: a comment on the patient global assessment criterion

Rheumatology (Oxford, England), 2012-06, Vol.51 (6), p.1076-1080

2012

Volltextzugriff (PDF)

Limited validity of the American College of Rheumatology criteria for classifying patients with gout in primary care

Annals of the rheumatic diseases, 2010-06, Vol.69 (6), p.1097-1256

2010

Volltextzugriff (PDF)

Impact of Stopping Tumor Necrosis Factor Inhibitors on Rheumatoid Arthritis Patients’ Burden of Disease

Arthritis care & research (2010), 2018-04, Vol.70 (4), p.516-524

2018

Volltextzugriff (PDF)

1 – 25 von 129

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(94)

Publikationsform

Artikel
(129)

Sprache

Englisch
(129)
Japanisch
(22)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(129)
Middle Aged
(125)
Female
(124)
Male
(120)
Science & Technology
(120)
Life Sciences & Biomedicine
(116)
Adult
(107)
Rheumatology
(104)
Rheumatoid Arthritis
(80)
Arthritis, Rheumatoid - Drug Therapy
(58)
Severity Of Illness Index
(54)
Biological And Medical Sciences
(47)
Medical Sciences
(46)
Diseases Of The Osteoarticular System
(38)
Antirheumatic Agents - Therapeutic Use
(36)
Inflammatory Joint Diseases
(35)
Treatment Outcome
(35)
Cohort Studies
(33)
Follow-Up Studies
(26)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis

Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study

The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients

Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis

How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Rituximab treatment in patients with refractory inflammatory myopathies

Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs

A tailored-guided internet-based cognitive-behavioral intervention for patients with rheumatoid arthritis as an adjunct to standard rheumatological care: results of a randomized controlled trial

Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries

Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort

Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry

Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry

A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry

Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology

Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39

Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration

Adalimumab drug and antidrug antibody levels do not predict flare risk after stopping adalimumab in RA patients with low disease activity

Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis

Time to achieve remission determines time to be in remission

Implementation of the EULAR cardiovascular risk management guideline in patients with rheumatoid arthritis: results of a successful collaboration between primary and secondary care

The provisional ACR/EULAR definition of remission in RA: a comment on the patient global assessment criterion

Limited validity of the American College of Rheumatology criteria for classifying patients with gout in primary care

Impact of Stopping Tumor Necrosis Factor Inhibitors on Rheumatoid Arthritis Patients’ Burden of Disease

Aktive Filter

Suchergebnisse filtern